The molecular pathology of melanoma: An integrated taxonomy of melanocytic neoplasia, Annu. Rev. Pathol, vol.9, pp.239-271, 2014. ,
Revisiting determinants of prognosis in cutanous melanoma, Cancer, vol.121, pp.4108-4123, 2015. ,
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas, Head Neck Pathol, vol.11, pp.110-117, 2017. ,
World Health Organization Classification of Tumours, In Pathology and Genetics of Skin Tumours, 2006. ,
Superficial spreading and nodular melanoma are distinct biological entities: A challenge to the linear progression model, Melanoma Res, vol.22, pp.1-8, 2012. ,
From mutations to medicine, Genes Dev, vol.26, pp.1131-1155, 2012. ,
, Genes, vol.10, 2019.
Cutaneous melanoma: From pathogenesis to therapy (Review), Int. J. Oncol, vol.52, pp.1071-1080, 2018. ,
, Melanoma Stem Cells and Metastasis: Mimicking Hematopoietic Cell Trafficking? Lab. Investig, vol.94, pp.13-30, 2014.
Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma, J. Pathol, vol.230, pp.261-269, 2013. ,
The natural history and patterns of metastases from mucosal melanoma: An analysis of 706 prospectively-followed patients, Ann. Oncol, vol.28, pp.868-873, 2017. ,
Improving the diagnosis and treatment of acral melanocytic lesions. Melanoma Manag, vol.4, pp.113-123, 2017. ,
Mucosal Melanoma: A Literature Review, Curr. Oncol. Rep, vol.20, 2018. ,
Rising Incidence of Mucosal Melanoma of the Head and Neck in the United States, J. Skin Cancer, 2012. ,
Evolving Therapeutic Strategies in Mucosal Melanoma Have not Improved Survival Over Five Decades, p.25, 2019. ,
Epidemiological trends in uveal melanoma, Br. J. Ophthalmol, vol.99, pp.1550-1553, 2015. ,
Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment, Ophthalmology, vol.107, pp.1443-1449, 2000. ,
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma, Cancer Cell, vol.33, p.151, 2018. ,
Cross-species models of human melanoma, J. Pathol, vol.238, pp.152-165, 2016. ,
Dogs as a Model for Cancer, Annu. Rev. Anim. Biosci, vol.4, pp.199-222, 2016. ,
Canine Cancer Genomics: Lessons for Canine and Human Health, Annu. Rev. Anim. Biosci, vol.7, pp.449-472, 2019. ,
Comparative oncology: What dogs and other species can teach us about humans with cancer, Philos. Trans. R. Soc. B. Biol. Sci, vol.370, 2015. ,
Discovery of Human-Similar Gene Fusions in Canine Cancers, Cancer Res, vol.77, pp.5721-5727, 2017. ,
Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma, Chromosome Res, vol.22, pp.305-319, 2014. ,
Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer-Evidence for a Relevant Model System and Urine-Based Diagnostic Test, Mol. Cancer Res, vol.13, pp.993-1002, 2015. ,
Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background, Genome Res, vol.25, pp.1634-1645, 2015. ,
SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma, Cancer Res, vol.78, pp.3421-3431, 2018. ,
, Genes, vol.10, 2019.
Genome-Wide Association Study of Golden Retrievers Identifies Germ-Line Risk Factors Predisposing to Mast Cell Tumours, PLoS Genet, vol.11, 2015. ,
Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs, Vet. Comp. Oncol, vol.16, pp.220-228, 2018. ,
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis ,
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma, Nat. Commun, vol.10, 2019. ,
, Comparative Aspects of Canine Melanoma. Vet. Sci, vol.3, issue.7, 2016.
Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas, Int. J. Mol. Sci, vol.19, 2018. ,
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma, Pigment Cell Melanoma Res, vol.27, pp.37-47, 2014. ,
Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas, Pigment Cell Melanoma Res, vol.27, pp.90-102, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01002709
Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy, Int. J. Mol. Sci, vol.19, 2018. ,
The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia, Vet. Pathol, vol.43, pp.136-149, 2006. ,
A comparative review of melanocytic neoplasms, Vet. Pathol, vol.39, pp.651-678, 2002. ,
Withrow and MacEwen's Small Animal Clinical Oncology, pp.978-979, 2013. ,
A prospective study of 420 canine melanocytic tumors: survival analysis and prognostic factors, 2019. ,
Malignant melanoma in 63 dogs, The effect of carboplatin chemotherapy on survival, vol.61, pp.25-31, 2001. ,
Histologic features and clinical outcomes of melanomas of lip, haired skin, and nail bed locations of dogs, J. Vet. Diagn. Investig, vol.18, pp.422-425, 2006. ,
Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases, Vet. Pathol, vol.37, pp.597-608, 2000. ,
Canine oral melanoma, Clin. Tech. Small Anim. Pract, vol.22, pp.55-60, 2007. ,
Breed-predispositions to cancer in pedigree dogs, ISRN Vet. Sci, 2013. ,
Malignant anal sac melanoma in dogs: Eleven cases, J. Small Anim. Pract, vol.58, pp.231-237, 2000. ,
Spontaneous Intestinal Melanoma in Dogs, vol.19, pp.1051-1054, 2005. ,
Intranasal malignant melanoma in a dog, J. Am. Anim. Hosp. Assoc, vol.42, pp.472-476, 2006. ,
, Genes, vol.10, 2019.
Intranasal melanoma treated with radiation therapy in three dogs, vol.37, pp.274-281, 2017. ,
Primary intranasal melanoma with brain invasion in a dog, Can. Vet. J, vol.58, pp.391-396, 2017. ,
A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation, Vet. Radiol. Ultrasound, vol.44, pp.352-359, 2003. ,
Outcome and prognostic factors following curative-intent surgery for oral tumours in dogs: 234 cases, J. Small Anim. Pract, vol.58, pp.146-153, 2004. ,
Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases, J. Am. Vet. Med. Assoc, vol.245, pp.1266-1273, 1998. ,
Prognostic markers for canine melanocytic neoplasms: A comparative review of the literature and goals for future investigation, Vet. Pathol, vol.48, pp.54-72, 2011. ,
Proliferation activity in oral and cutaneous canine melanocytic tumours: Correlation with histological parameters, location, and clinical behaviour, Res. Vet. Sci, vol.73, pp.45-51, 2002. ,
Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity, Vet. Pathol, vol.45, pp.889-896, 2008. ,
Hemimaxillectomy for the treatment of oral tumors in 69 dogs, Vet. Surg, vol.21, pp.337-341, 1992. ,
Results of Partial Mandibulectomy for the Treatment of Oral Tumors in 142 Dogs, Vet. Surg, vol.20, pp.397-401, 1991. ,
Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases, J. Am. Vet. Med. Assoc, vol.245, pp.401-407, 2001. ,
Palliative radiation therapy for solid tumors in dogs: 103 cases, J. Am. Vet. Med. Assoc, vol.248, pp.72-82, 2007. ,
Oral malignant melanoma-The effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy, Vet. Comp. Oncol, vol.3, pp.222-229, 2005. ,
Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases, J. Am. Vet. Med. Assoc, vol.247, pp.1146-1153, 2006. ,
Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma, Vet. Comp. Oncol, vol.14, pp.146-157, 2016. ,
0-7-21 radiation therapy for the treatment of canine oral melanoma, J. Vet. Intern. Med, vol.8, pp.267-272, 1994. ,
Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997), J. Vet. Intern. Med, vol.17, pp.96-101, 2003. ,
Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats, Am. J. Vet. Res, vol.63, pp.1129-1133, 2002. ,
Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases, J. Am. Vet. Med. Assoc, vol.218, pp.1444-1448, 1989. ,
Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma, Cancer Immun, vol.6, 2006. ,
Cancer immunology and canine malignant melanoma: A comparative review, Vet. Immunol. Immunopathol, vol.169, pp.15-26, 2016. ,
A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma, Vet. Comp. Oncol, vol.11, pp.219-229, 2013. ,
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor, Am. J. Vet. Res, vol.72, pp.1631-1638, 2011. ,
Use of the melanoma vaccine in 38 dogs: The South African experience, J. S. Afr. Vet. Assoc, vol.86, 1246. ,
A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma, J. Vet. Med. Sci, vol.78, pp.845-850, 2016. ,
Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK, J. Small Anim. Pract, vol.58, pp.10-16, 2017. ,
Canine oral melanoma: Comparison of surgery versus surgery plus Corynebacterium parvum, Cancer Investig, vol.4, pp.397-402, 1986. ,
Prognostic evaluation of Ki67 threshold value in canine oral melanoma, Vet. Pathol, vol.48, pp.41-53, 2011. ,
Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas, Vet. Comp. Oncol, vol.9, pp.219-224, 2011. ,
BRAF Mutations in Canine Cancers, PLoS ONE, vol.10, 2015. ,
Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization, Chromosome Res, vol.23, pp.171-186, 2015. ,
Integrated Genetic Analysis of Canine Mucosal Melanoma from Three Predisposed Breeds, 2019. ,
, Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell, vol.161, pp.1681-1696, 2015.
Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets, J. Pathol, vol.244, pp.358-366, 2018. ,
Whole-genome landscapes of major melanoma subtypes, Nature, vol.545, pp.175-180, 2017. ,
Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma, Science, vol.362, pp.1055-1060, 2018. ,
Mutation status among patients with sinonasal mucosal melanoma and its impact on survival, Br. J. Cancer, vol.116, pp.1564-1571, 2017. ,
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma, Melanoma Res, vol.27, pp.189-199, 2017. ,
Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression, Sci. Rep, vol.9, p.6511, 2019. ,
Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma, Vet. Comp. Oncol, vol.13, pp.288-304, 2015. ,
Update in genetic susceptibility in melanoma, Ann. Transl. Med, 2015. ,
The molecular basis of canine melanoma: Pathogenesis and trends in diagnosis and therapy, J. Vet. Intern. Med, vol.13, pp.163-174, 1999. ,
Prognosis after surgical excision of canine melanomas, Vet. Pathol, vol.16, pp.32-40, 1979. ,
MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma, Vet. Dermatol, vol.12, pp.139-147, 2001. ,
Pigmented lesions of the skin, Clin. Dermatol, vol.12, pp.507-514, 1994. ,
Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors, Vet. Pathol, 2018. ,
Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases, Can. Vet. J, vol.59, pp.981-987, 2003. ,
The genomic landscape of cutaneous melanoma, Pigment Cell Melanoma Res, vol.29, pp.266-283, 2016. ,
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma, Nat. Genet, vol.47, pp.987-995, 2015. ,
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways, Nat. Commun, vol.9, 2018. ,
Diagnoses and clinical outcomes associated with surgically amputated canine digits submitted to multiple veterinary diagnostic laboratories, Vet. Pathol, vol.44, pp.355-361, 2007. ,
Canine digital tumors: A veterinary cooperative oncology group retrospective study of 64 dogs, J. Vet. Intern. Med, vol.19, pp.720-724, 2005. ,
Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs, J. Vet. Intern. Med, vol.25, pp.94-99, 2011. ,
Evaluation of dogs with digit masses: 117 cases (1981-1991), J. Am. Vet. Med. Assoc, vol.207, pp.726-728, 1995. ,
Distinct sets of genetic alterations in melanoma, N. Engl. J. Med, vol.353, pp.2135-2147, 2005. ,
Morphology and behavior of primary ocular melanomas in 91 dogs, Vet. Pathol, vol.23, pp.418-424, 1986. ,
Primary Ocular Melanoma in Dogs, Vet. Pathol, vol.20, pp.379-395, 1983. ,
A matched observational study of canine survival with primary intraocular melanocytic neoplasia, Vet. Ophthalmol, vol.2, pp.185-190, 1999. ,
Melanocytoma-like melanoma may be the missing link between benign and malignant uveal melanocytic lesions in humans and dogs: A comparative study, Melanoma Res, vol.26, pp.565-571, 2016. ,
Investigation of prognostic indicators for human uveal melanoma as biomarkers of canine uveal melanoma metastasis, J. Small Anim. Pract, vol.54, pp.584-593, 2013. ,
Canine uveal melanoma: Series and literature review, J. Am. Anim. Hosp. Assoc, vol.23, pp.415-422, 1987. ,
Suspected latent vertebral metastasis of uveal melanoma in a dog: A case report, Vet. Ophthalmol, vol.4, pp.75-77, 2001. ,
Late prostatic metastasis of an uveal melanoma in a miniature Schnauzer dog, Clin. Case Rep, vol.4, pp.647-652, 2016. ,
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26, Arch. Ophthalmol, vol.123, pp.1639-1643, 2005. ,
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma, J. Mol. Diagn, vol.12, pp.461-468, 2010. ,
Immunohistochemical Expression of FXR1 in Canine Normal Tissues and Melanomas, J. Histochem. Cytochem, vol.66, pp.585-593, 2018. ,
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, vol.457, pp.599-602, 2009. ,
Genetic and clinico-pathologic analysis of metastatic uveal melanoma, Mod. Pathol, vol.27, pp.175-183, 2014. ,
Mutations in GNA11 in uveal melanoma, N. Engl. J. Med, vol.363, pp.2191-2199, 2010. ,
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide, J. Natl. Cancer Inst, vol.110, pp.1328-1341, 2018. ,
Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma, BMC Cancer, vol.18, p.1172, 2018. ,
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus, NPJ Genom ,
Radiation Therapy for Cutaneous Melanoma, Dermatol. Clin, vol.30, pp.525-533, 2012. ,
Combatting mucosal melanoma: Recent advances and future perspectives. Melanoma Manag, vol.5, 2018. ,
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: Version 2.0, J. Immunother. Cancer, vol.6, p.44, 2018. ,
A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma, Vet. Sci, vol.6, 2019. ,
Targeted agents and immunotherapies: Optimizing outcomes in melanoma, Nat. Rev. Clin. Oncol, vol.14, pp.463-482, 2017. ,
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis, J. Clin. Oncol, vol.35, pp.226-235, 2017. ,
Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma, PLoS ONE, vol.13, 2018. ,
PD-1 expression by canine T cells and functional effects of PD-1 blockade, Vet. Comp. Oncol, vol.15, pp.1487-1502, 2017. ,
, Genes, vol.10, 2019.
Immune regulation of canine tumour and macrophage PD-L1 expression, Vet. Comp. Oncol, vol.15, pp.534-549, 2017. ,
Expression of PD-L1 on canine tumor cells and enhancement of IFN-? production from tumor-infiltrating cells by PD-L1 blockade, PLoS ONE, vol.9, 2014. ,
A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma ,
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin, J. Clin. Oncol, vol.31, pp.3182-3190, 2013. ,
The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo, Vet. J, vol.198, pp.577-582, 2013. ,
Survey of equine cutaneous neoplasia in the Pacific Northwest, J. Vet. Diagn. Investig, vol.18, pp.123-126, 2006. ,
A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse, Nat. Genet, vol.40, pp.1004-1009, 2008. ,
,
Mutation analysis and gene expression profiling of ocular melanomas in cats, Vet. Comp. Oncol, vol.15, pp.1403-1416, 2017. ,
Non-ocular melanomas in cats: A retrospective study of 30 cases, J. Feline Med. Surg, vol.19, pp.351-357, 2017. ,
Gene expression signature for spontaneous cancer regression in melanoma pigs, Neoplasia, vol.10, pp.714-726, 2008. ,
New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model, Oncotarget, vol.9, pp.27682-27697, 2018. ,
The Comparative Oncology Trials Consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway, PLoS Med, 2009. ,
Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology, Sci. Transl. Med, vol.8, 2016. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI